Search by Drug Name or NDC
NDC 62332-0618-31 Cyclophosphamide 25 mg/1 Details
Cyclophosphamide 25 mg/1
Cyclophosphamide is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is CYCLOPHOSPHAMIDE.
Product Information
| NDC | 62332-0618 |
|---|---|
| Product ID | 62332-618_1d719aa9-6f74-42a9-8010-b3d4f33d6f24 |
| Associated GPIs | |
| GCN Sequence Number | 071488 |
| GCN Sequence Number Description | cyclophosphamide CAPSULE 25 MG ORAL |
| HIC3 | V1A |
| HIC3 Description | ANTINEOPLASTIC - ALKYLATING AGENTS |
| GCN | 35317 |
| HICL Sequence Number | 003893 |
| HICL Sequence Number Description | CYCLOPHOSPHAMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Cyclophosphamide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cyclophosphamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | CYCLOPHOSPHAMIDE |
| Labeler Name | Alembic Pharmaceuticals Inc. |
| Pharmaceutical Class | Alkylating Activity [MoA], Alkylating Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215892 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62332-0618-31 (62332061831)
| NDC Package Code | 62332-618-31 |
|---|---|
| Billing NDC | 62332061831 |
| Package | 100 CAPSULE in 1 BOTTLE (62332-618-31) |
| Marketing Start Date | 2022-11-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |